This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Feb 28;351(9103):678; author reply 678-9.

doi: 10.1016/S0140-6736(05)78467-1.

Issues about pertussis vaccines

S Hurley, J Bennet, I Gust

PMID: 9500362
DOI: 10.1016/S0140-6736(05)78467-1

Comment

Issues about pertussis vaccines

S Hurley et al. Lancet. 1998.

. 1998 Feb 28;351(9103):678; author reply 678-9.

doi: 10.1016/S0140-6736(05)78467-1.

Authors

S Hurley, J Bennet, I Gust

PMID: 9500362
DOI: 10.1016/S0140-6736(05)78467-1

No abstract available

PubMed Disclaimer

Comment in

Acellular pertussis vaccines: progress but déjà vu.
Preston NW, Matthews RC. Preston NW, et al. Lancet. 1998 Jun 13;351(9118):1811-2. doi: 10.1016/S0140-6736(05)78773-0. Lancet. 1998. PMID: 9635974 No abstract available.

Comment on

Still more questions on pertussis vaccines.
Poland GA. Poland GA. Lancet. 1997 Nov 29;350(9091):1564-5. doi: 10.1016/S0140-6736(97)22048-9. Lancet. 1997. PMID: 9393330 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.